Anebulo Historical Financial Ratios

ANEB Stock  USD 3.08  1.00  48.08%   
Anebulo Pharmaceuticals is presently reporting on over 74 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 5.25 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Anebulo Pharmaceuticals financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.

About Anebulo Financial Ratios Analysis

Anebulo PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Anebulo Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Anebulo financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Anebulo Pharmaceuticals history.

Anebulo Pharmaceuticals Financial Ratios Chart

At present, Anebulo Pharmaceuticals' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 0.39, whereas Free Cash Flow Yield is projected to grow to (0.18).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.

Net Debt To E B I T D A

A leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA).
Most ratios from Anebulo Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Anebulo Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.At present, Anebulo Pharmaceuticals' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 0.39, whereas Free Cash Flow Yield is projected to grow to (0.18).
 2021 2022 2023 2024 (projected)
Current Ratio28.3921.0424.240.06
Net Debt To EBITDA2.130.951.11.04

Anebulo Pharmaceuticals fundamentals Correlations

0.91-0.82-0.93-0.521.0-0.931.0-0.830.530.891.0-0.91.0-0.64-0.981.01.0-0.931.0-0.91-0.990.680.910.860.91
0.91-0.52-0.71-0.270.91-0.710.94-0.920.271.00.91-0.660.91-0.81-0.90.910.91-0.860.91-0.76-0.840.871.00.971.0
-0.82-0.520.970.75-0.820.97-0.760.54-0.78-0.49-0.830.92-0.830.320.84-0.82-0.820.82-0.820.910.88-0.3-0.52-0.5-0.52
-0.93-0.710.970.73-0.931.0-0.90.69-0.72-0.68-0.940.96-0.940.490.94-0.94-0.930.9-0.940.960.97-0.49-0.71-0.67-0.71
-0.52-0.270.750.73-0.520.73-0.480.35-0.8-0.23-0.530.65-0.530.360.56-0.53-0.520.6-0.530.690.58-0.26-0.27-0.25-0.27
1.00.91-0.82-0.93-0.52-0.931.0-0.830.530.891.0-0.91.0-0.64-0.981.01.0-0.931.0-0.91-0.990.680.910.860.91
-0.93-0.710.971.00.73-0.93-0.90.69-0.72-0.68-0.940.96-0.940.490.94-0.94-0.930.9-0.940.960.97-0.49-0.71-0.67-0.71
1.00.94-0.76-0.9-0.481.0-0.9-0.850.490.930.99-0.870.99-0.68-0.980.991.0-0.920.99-0.89-0.970.730.940.890.94
-0.83-0.920.540.690.35-0.830.69-0.85-0.35-0.92-0.820.53-0.820.940.89-0.82-0.830.93-0.820.830.75-0.95-0.92-0.98-0.92
0.530.27-0.78-0.72-0.80.53-0.720.49-0.350.230.54-0.680.54-0.23-0.580.540.53-0.590.54-0.69-0.580.160.270.260.27
0.891.0-0.49-0.68-0.230.89-0.680.93-0.920.230.89-0.630.89-0.82-0.880.890.89-0.840.89-0.74-0.820.881.00.971.0
1.00.91-0.83-0.94-0.531.0-0.940.99-0.820.540.89-0.911.0-0.63-0.981.01.0-0.931.0-0.92-0.990.670.910.850.91
-0.9-0.660.920.960.65-0.90.96-0.870.53-0.68-0.63-0.91-0.910.30.86-0.91-0.90.77-0.910.840.96-0.32-0.66-0.55-0.66
1.00.91-0.83-0.94-0.531.0-0.940.99-0.820.540.891.0-0.91-0.63-0.981.01.0-0.931.0-0.92-0.990.670.910.850.91
-0.64-0.810.320.490.36-0.640.49-0.680.94-0.23-0.82-0.630.3-0.630.72-0.63-0.640.79-0.630.670.54-0.99-0.81-0.9-0.81
-0.98-0.90.840.940.56-0.980.94-0.980.89-0.58-0.88-0.980.86-0.980.72-0.98-0.980.98-0.980.970.96-0.73-0.9-0.88-0.9
1.00.91-0.82-0.94-0.531.0-0.940.99-0.820.540.891.0-0.911.0-0.63-0.981.0-0.931.0-0.92-0.990.670.910.850.91
1.00.91-0.82-0.93-0.521.0-0.931.0-0.830.530.891.0-0.91.0-0.64-0.981.0-0.931.0-0.92-0.990.680.910.860.91
-0.93-0.860.820.90.6-0.930.9-0.920.93-0.59-0.84-0.930.77-0.930.790.98-0.93-0.93-0.930.980.9-0.79-0.86-0.89-0.86
1.00.91-0.82-0.94-0.531.0-0.940.99-0.820.540.891.0-0.911.0-0.63-0.981.01.0-0.93-0.92-0.990.670.910.850.91
-0.91-0.760.910.960.69-0.910.96-0.890.83-0.69-0.74-0.920.84-0.920.670.97-0.92-0.920.98-0.920.91-0.65-0.76-0.78-0.76
-0.99-0.840.880.970.58-0.990.97-0.970.75-0.58-0.82-0.990.96-0.990.540.96-0.99-0.990.9-0.990.91-0.57-0.84-0.77-0.84
0.680.87-0.3-0.49-0.260.68-0.490.73-0.950.160.880.67-0.320.67-0.99-0.730.670.68-0.790.67-0.65-0.570.870.940.87
0.911.0-0.52-0.71-0.270.91-0.710.94-0.920.271.00.91-0.660.91-0.81-0.90.910.91-0.860.91-0.76-0.840.870.971.0
0.860.97-0.5-0.67-0.250.86-0.670.89-0.980.260.970.85-0.550.85-0.9-0.880.850.86-0.890.85-0.78-0.770.940.970.97
0.911.0-0.52-0.71-0.270.91-0.710.94-0.920.271.00.91-0.660.91-0.81-0.90.910.91-0.860.91-0.76-0.840.871.00.97
Click cells to compare fundamentals

Anebulo Pharmaceuticals Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Anebulo Stock

When determining whether Anebulo Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anebulo Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anebulo Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anebulo Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anebulo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Return On Assets
(0.58)
Return On Equity
(1.04)
The market value of Anebulo Pharmaceuticals is measured differently than its book value, which is the value of Anebulo that is recorded on the company's balance sheet. Investors also form their own opinion of Anebulo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Anebulo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anebulo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Anebulo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anebulo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anebulo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anebulo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.